Silencing mitogen-activated protein kinase-activated protein kinase-2 arrests inflammatory bone loss

Journal of Pharmacology and Experimental Therapeutics

Volumn 336, Issue 3, 2011, Pages 633-642

  Li, Qiyan ^a   Yu, Hong ^a   Zinna, Robert ^a   Martin, Kylie ^a   Herbert, Bethany ^a   Liu, Angen ^a   Rossa Jr , Carlos ^a   Kirkwood, Keith L ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; SMALL INTERFERING RNA;

ALVEOLAR BONE LOSS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE SILENCING; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY INFILTRATE; MALE; MAXILLA; MOUTH; NONHUMAN; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; RAT;

ALVEOLAR BONE LOSS; ANIMALS; CELL LINE; CELLS, CULTURED; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; INFLAMMATION; INFLAMMATION MEDIATORS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING;

EID: 79951995572     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.172395     Document Type: Article

References (27)

1. Ajizian SJ, English BK, and Meals EA (1999) Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma. J Infect Dis 179:939-944. (Pubitemid 29159340)
2. Carballo E, Lai WS, and Blackshear PJ (1998) Feedback inhibition of macrophage tumor necrosis factor-α production by tristetraprolin. Science 281:1001-1005. (Pubitemid 28399252)
3. Chrestensen CA, Schroeder MJ, Shabanowitz J, Hunt DF, Pelo JW, Worthington MT, and Sturgill TW (2004) MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding. J Biol Chem 279:10176-10184. (Pubitemid 38372622)
4. Christoph T, Grünweller A, Mika J, Schäfer MK, Wade EJ, Weihe E, Erdmann VA, Frank R, Gillen C, and Kurreck J (2006) Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo. Biochem Biophys Res Commun 350:238-243. (Pubitemid 44466599)
5. Dean JL, Brook M, Clark AR, and Saklatvala J (1999) p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide- treated human monocytes. J Biol Chem 274:264-269. (Pubitemid 29035058)
6. Difeo A, Huang F, Sangodkar J, Terzo EA, Leake D, Narla G, and Martignetti JA (2009) KLF6-SV1 is a novel antiapoptotic protein that targets the BH3-only protein NOXA for degradation and whose inhibition extends survival in an ovarian cancer model. Cancer Res 69:4733-4741.
7. Hegen M, Gaestel M, Nickerson-Nutter CL, Lin LL, and Telliez JB (2006) MAPKAP kinase 2-deficient mice are resistant to collagen-induced arthritis. J Immunol 177:1913-1917. (Pubitemid 44092531)
8. Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, Radzioch D, Clark AR, Blackshear PJ, Kotlyarov A, and Gaestel M (2006) Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol 26:2399-2407. (Pubitemid 43346938)
9. Kirkwood KL, Li F, Rogers JE, Otremba J, Coatney DD, Kreider JM, D'Silva NJ, Chakravarty S, Dugar S, Higgins LS, et al. (2007) A p38α selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss. J Pharmacol Exp Ther 320:56-63. (Pubitemid 46025719)
10. Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, Volk HD, and Gaestel M (1999) MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis. Nat Cell Biol 1:94-97. (Pubitemid 129501950)
11. Lee JC and Young PR (1996) Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J Leukoc Biol 59:152-157. (Pubitemid 26098701)
12. Mbalaviele G, Anderson G, Jones A, De Ciechi P, Settle S, Mnich S, Thiede M, Abu-Amer Y, Portanova J, and Monahan J (2006) Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction. J Pharmacol Exp Ther 317:1044-1053. (Pubitemid 43764107)
13. Neininger A, Kontoyiannis D, Kotlyarov A, Winzen R, Eckert R, Volk HD, Holtmann H, Kollias G, and Gaestel M (2002) MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels. J Biol Chem 277:3065-3068. (Pubitemid 34953164)
14. Palliser D, Chowdhury D, Wang QY, Lee SJ, Bronson RT, Knipe DM, and Lieberman J (2006) An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 439:89-94. (Pubitemid 43053634)
15. Patil C, Rossa C Jr, and Kirkwood KL (2006) Actinobacillus actinomycetemcomitans lipopolysaccharide induces interleukin-6 expression through multiple mitogen-activated protein kinase pathways in periodontal ligament fibroblasts. Oral Microbiol Immunol 21:392-398. (Pubitemid 44630185)
16. Patil C, Zhu X, Rossa C Jr., Kim YJ, and Kirkwood KL (2004) p38 MAPK regulates IL-1β induced IL-6 expression through mRNA stability in osteoblasts. Immunol Invest 33:213-233. (Pubitemid 38685932)
17. Patil CS, Liu M, Zhao W, Coatney DD, Li F, VanTubergen EA, D'Silva NJ, and Kirkwood KL (2008) Targeting mRNA stability arrests inflammatory bone loss. Mol Ther 16:1657-1664.
18. Rao KM (2001) MAP kinase activation in macrophages. J Leukoc Biol 69:3-10.
19. Ridley SH, Sarsfield SJ, Lee JC, Bigg HF, Cawston TE, Taylor DJ, DeWitt DL, and Saklatvala J (1997) Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J Immunol 158:3165-3173. (Pubitemid 127484030)
20. Rogers JE, Li F, Coatney DD, Otremba J, Kriegl JM, Protter TA, Higgins LS, Medicherla S, and Kirkwood KL (2007a) A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model. J Periodontol 78:1992-1998.
21. Rogers JE, Li F, Coatney DD, Rossa C, Bronson P, Krieder JM, Giannobile WV, and Kirkwood KL (2007b) Actinobacillus actinomycetemcomitans lipopolysaccharide-mediated experimental bone loss model for aggressive periodontitis. J Periodontol 78:550-558.
22. Rossa C Jr., Liu M, Bronson P, and Kirkwood KL (2007) Transcriptional activation of MMP-13 by periodontal pathogenic LPS requires p38 MAP kinase. J Endotoxin Res 13:85-93. (Pubitemid 47471324)
23. Rossa C Jr., Liu M, Patil C, and Kirkwood KL (2005) MKK3/6-p38 MAPK negatively regulates murine MMP-13 gene expression induced by IL-1β and TNF-α in immortalized periodontal ligament fibroblasts. Matrix Biol 24:478-488. (Pubitemid 41443275)
24. Sartori R, Li F, and Kirkwood KL (2009) MAP kinase phosphatase-1 protects against inflammatory bone loss. J Dent Res 88:1125-1130.
25. Stokoe D, Campbell DG, Nakielny S, Hidaka H, Leevers SJ, Marshall C, and Cohen P (1992) MAPKAP kinase-2; a novel protein kinase activated by mitogen-activated protein kinase. EMBO J 11:3985-3994.
26. Underwood DC, Osborn RR, Bochnowicz S, Webb EF, Rieman DJ, Lee JC, Romanic AM, Adams JL, Hay DW, and Griswold DE (2000) SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am J Physiol Lung Cell Mol Physiol 279:L895-L902.
27. Zimmermann TS, Lee AC, Akinc A, Bramlage B, Bumcrot D, Fedoruk MN, Harborth J, Heyes JA, Jeffs LB, John M, et al. (2006) RNAi-mediated gene silencing in non-human primates. Nature 441:111-114.